company background image
4171

GeneReach Biotechnology TPEX:4171 Stock Report

Last Price

NT$53.10

Market Cap

NT$2.4b

7D

-8.4%

1Y

-38.9%

Updated

02 Oct, 2022

Data

Company Financials
4171 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends4/6

4171 Stock Overview

GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan.

GeneReach Biotechnology Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GeneReach Biotechnology
Historical stock prices
Current Share PriceNT$53.10
52 Week HighNT$171.82
52 Week LowNT$50.10
Beta0.47
1 Month Change-37.13%
3 Month Change-32.16%
1 Year Change-38.89%
3 Year Change45.07%
5 Year Change167.26%
Change since IPO43.17%

Recent News & Updates

Shareholder Returns

4171TW Medical EquipmentTW Market
7D-8.4%-3.9%-5.0%
1Y-38.9%-8.3%-18.0%

Return vs Industry: 4171 underperformed the TW Medical Equipment industry which returned -8.3% over the past year.

Return vs Market: 4171 underperformed the TW Market which returned -18% over the past year.

Price Volatility

Is 4171's price volatile compared to industry and market?
4171 volatility
4171 Average Weekly Movement7.8%
Medical Equipment Industry Average Movement5.4%
Market Average Movement5.1%
10% most volatile stocks in TW Market8.3%
10% least volatile stocks in TW Market2.4%

Stable Share Price: 4171 is more volatile than 75% of TW stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: 4171's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
2004n/aGrace Changhttps://www.genereach.com

GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers pathogen detection platforms, including equipment and reagents; and animal use medicines, biotechnology services, medical materials and equipment, and precision instruments. The company also provides polymerase chain reaction training programs, molecular diagnostic technical solutions, laboratory installation services, OEM/ODM contract manufacturing services, and research collaboration services.

GeneReach Biotechnology Corp. Fundamentals Summary

How do GeneReach Biotechnology's earnings and revenue compare to its market cap?
4171 fundamental statistics
Market CapNT$2.44b
Earnings (TTM)NT$410.82m
Revenue (TTM)NT$1.06b

5.9x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4171 income statement (TTM)
RevenueNT$1.06b
Cost of RevenueNT$305.70m
Gross ProfitNT$757.17m
Other ExpensesNT$346.35m
EarningsNT$410.82m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)8.94
Gross Margin71.24%
Net Profit Margin38.65%
Debt/Equity Ratio20.5%

How did 4171 perform over the long term?

See historical performance and comparison

Dividends

8.6%

Current Dividend Yield

51%

Payout Ratio